These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12092437)

  • 1. Multiple sclerosis update.
    Mayr WT; Rodriguez M
    Minn Med; 2002 Jun; 85(6):36-9. PubMed ID: 12092437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple sclerosis--symptoms, diagnosis and treatment].
    Elíasdóttir OJ; Olafsson E; Kjartansson O
    Laeknabladid; 2009 Sep; 95(9):583-9. PubMed ID: 19738293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
    Jarius S; Hohlfeld R; Voltz R
    MMW Fortschr Med; 2003 May; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and treatment of multiple sclerosis.
    Weinshenker BG; Sibley WA
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):203-11. PubMed ID: 1377973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of multiple sclerosis.
    Calabresi PA
    Am Fam Physician; 2004 Nov; 70(10):1935-44. PubMed ID: 15571060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MS Therapy Consensus Group. Immunomodulating staged therapy of multiple sclerosis].
    Nervenarzt; 1999 Apr; 70(4):371-86. PubMed ID: 10355003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care management of multiple sclerosis.
    Holland N
    Adv Nurse Pract; 1999 Mar; 7(3):26-32; quiz 33-4. PubMed ID: 10373797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent therapeutic strategy for multiple sclerosis].
    Itoyama Y
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1214-7. PubMed ID: 12235841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
    Schwid SR; Panitch HS
    Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: from cure to care.
    Dubois B
    Verh K Acad Geneeskd Belg; 2009; 71(5):295-300. PubMed ID: 20232785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: common management issues.
    McDonald E
    Aust Fam Physician; 1992 Oct; 21(10):1421-4. PubMed ID: 1280093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta1a treatment for multiple sclerosis.
    Sandberg-Wollheim M
    Expert Rev Neurother; 2005 Jan; 5(1):25-34. PubMed ID: 15853471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The history of multiple sclerosis: the changing frame of the disease over the centuries.
    Murray TJ
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S3-8. PubMed ID: 19200863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis.
    Motamed MR; Najimi N; Fereshtehnejad SM
    Clin Neurol Neurosurg; 2007 May; 109(4):344-9. PubMed ID: 17300863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pediatric multiple sclerosis and variants.
    Pohl D; Waubant E; Banwell B; Chabas D; Chitnis T; Weinstock-Guttman B; Tenembaum S;
    Neurology; 2007 Apr; 68(16 Suppl 2):S54-65. PubMed ID: 17438239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.